{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:28:37Z","timestamp":1787020117238,"version":"build-2736575974"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T00:00:00Z","timestamp":1717804800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T00:00:00Z","timestamp":1717804800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Anesthesiol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Remimazolam is a recently developed, ultrashort-acting benzodiazepine that is used as a general anesthetic. Some cases of remimazolam anaphylaxis have been reported, but its characteristics are not fully understood. We present an interesting case report and review of the literature to better understand remimazolam anaphylaxis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>\n                      A 75-year-old man scheduled for robot-assisted gastrectomy was administered remimazolam for the induction of general anesthesia. After intubation, low end-expiratory CO\n                      <jats:sub>2<\/jats:sub>\n                      , high airway pressure and concurrent circulatory collapse were observed. Bronchoscopy revealed marked tracheal and bronchial edema, which we diagnosed as anaphylaxis. The patient suffered cardiac arrest after bronchoscopy but recovered immediately with intravenous adrenaline administration and chest compressions. We performed skin prick tests for the drugs used during induction except for remimazolam, considering the high risk of systemic adverse reactions to remimazolam. We diagnosed remimazolam anaphylaxis because the skin prick test results for the other drugs used during anesthesia were negative, and these drugs could have been used without allergic reactions during the subsequent surgery. Furthermore, this patient had experienced severe anaphylactic-like reactions when he underwent cardiac surgery a year earlier, in which midazolam had been used, but it was not thought to be the allergen at that time. Based on these findings, cross-reactivity to remimazolam and midazolam was suspected. However, the patient had previously received another benzodiazepine, brotizolam, to which he was not allergic, suggesting that cross-reactivity of remimazolam may vary among benzodiazepines. In this article, we reviewed the 11 cases of remimazolam anaphylaxis that have been described in the literature.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Remimazolam is an ultrashort-acting sedative; however, it can cause life-threatening anaphylaxis. In addition, its cross-reactivity with other benzodiazepines is not fully understood. To increase the safety of this drug, further research and more experience in its use are needed.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12871-024-02591-w","type":"journal-article","created":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T06:01:29Z","timestamp":1717826489000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Remimazolam anaphylaxis in a patient not allergic to brotizolam: a case report and literature review"],"prefix":"10.1186","volume":"24","author":[{"given":"Toshihiro","family":"Nakai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eisuke","family":"Kako","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruko","family":"Ota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MinHye","family":"So","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuya","family":"Sobue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,8]]},"reference":[{"key":"2591_CR1","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s00540-020-02755-1","volume":"34","author":"K Masui","year":"2020","unstructured":"Masui K. Remimazolam besilate, a benzodiazepine, has been approved for general anesthesia!! J Anesth. 2020;34:479\u201382.","journal-title":"J Anesth"},{"key":"2591_CR2","doi-asserted-by":"publisher","first-page":"3957","DOI":"10.2147\/DDDT.S384155","volume":"16","author":"Q Hu","year":"2022","unstructured":"Hu Q, Liu X, Wen C, Li D, Lei X. Remimazolam: An Updated Review of a New Sedative and Anaesthetic. Drug Des Devel Ther. 2022;16:3957\u201374.","journal-title":"Drug Des Devel Ther"},{"key":"2591_CR3","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1213\/ANE.0b013e31823f0c28","volume":"115","author":"LJ Antonik","year":"2012","unstructured":"Antonik LJ, Goldwater DR, Kilpatrick GJ, Tilbrook GS, Borkett KM. A placebo- and midazolam-controlled phase I single ascending-dose study evaluating the safety, pharmacokinetics, and pharmacodynamics of remimazolam (CNS 7056): Part I. Safety, efficacy, and basic pharmacokinetics. Anesth Analg. 2012;115:274\u201383.","journal-title":"Anesth Analg."},{"key":"2591_CR4","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s00540-020-02788-6","volume":"34","author":"M Doi","year":"2020","unstructured":"Doi M, Morita K, Takeda J, Sakamoto A, Yamakage M, Suzuki T. Efficacy and safety of remimazolam versus propofol for general anesthesia: a multicenter, single-blind, randomized, parallel-group, phase IIb\/III trial. J Anesth. 2020;34:543\u201353.","journal-title":"J Anesth."},{"key":"2591_CR5","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s00540-020-02776-w","volume":"34","author":"M Doi","year":"2020","unstructured":"Doi M, Hirata N, Suzuki T, Morisaki H, Morimatsu H, Sakamoto A. Safety and efficacy of remimazolam in induction and maintenance of general anesthesia in high-risk surgical patients (ASA Class III): results of a multicenter, randomized, double-blind, parallel-group comparative trial. J Anesth. 2020;34:491\u2013501.","journal-title":"J Anesth."},{"key":"2591_CR6","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1186\/s12871-021-01530-3","volume":"21","author":"T Nakanishi","year":"2021","unstructured":"Nakanishi T, Sento Y, Kamimura Y, Tsuji T, Kako E, Sobue K. Remimazolam for induction of anesthesia in elderly patients with severe aortic stenosis: a prospective, observational pilot study. BMC Anesthesiol. 2021;21:306.","journal-title":"BMC Anesthesiol"},{"key":"2591_CR7","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s40981-022-00508-5","volume":"8","author":"S Uchida","year":"2022","unstructured":"Uchida S, Takekawa D, Kitayama M, Hirota K. Two cases of circulatory collapse due to suspected remimazolam anaphylaxis. JA Clin Rep. 2022;8:18.","journal-title":"JA Clin Rep"},{"key":"2591_CR8","doi-asserted-by":"publisher","first-page":"e12167","DOI":"10.1002\/anr3.12167","volume":"10","author":"M Yamaoka","year":"2022","unstructured":"Yamaoka M, Kuroda K, Matsumoto N, Okazaki Y, Minami E, Yamashita C, Kurasako T. Remimazolam anaphylaxis confirmed by serum tryptase elevation and skin test. Anaesth Rep. 2022;10:e12167.","journal-title":"Anaesth Rep"},{"key":"2591_CR9","doi-asserted-by":"publisher","first-page":"e01616","DOI":"10.1213\/XAA.0000000000001616","volume":"16","author":"Y Hasushita","year":"2022","unstructured":"Hasushita Y, Nagao M, Miyazawa Y, Yunoki K, Mima H. Cardiac Arrest Following Remimazolam-Induced Anaphylaxis: a case report. A A Pract. 2022;16:e01616.","journal-title":"A A Pract"},{"key":"2591_CR10","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s12871-023-02052-w","volume":"23","author":"X Hu","year":"2023","unstructured":"Hu X, Tang Y, Fang X. Laryngeal edema following remimazolam-induced anaphylaxis: a rare clinical manifestation. BMC Anesthesiol. 2023;23:99.","journal-title":"BMC Anesthesiol"},{"key":"2591_CR11","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s00540-021-02934-8","volume":"35","author":"K Tsurumi","year":"2021","unstructured":"Tsurumi K, Takahashi S, Hiramoto Y, Nagumo K, Takazawa T, Kamiyama Y. Remimazolam anaphylaxis during anesthesia induction. J Anesth. 2021;35:571\u20135.","journal-title":"J Anesth"},{"key":"2591_CR12","doi-asserted-by":"publisher","first-page":"e122","DOI":"10.1016\/j.bja.2022.07.047","volume":"129","author":"KM Kim","year":"2022","unstructured":"Kim KM, Lee H, Bang JY, Choi BM, Noh GJ. Anaphylaxis following remimazolam administration during induction of anaesthesia. Br J Anaesth. 2022;129:e122\u20134.","journal-title":"Br J Anaesth"},{"key":"2591_CR13","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.anai.2023.09.015","volume":"132","author":"DBK Golden","year":"2024","unstructured":"Golden DBK, Wang J, Waserman S, Akin C, Campbell RL, Ellis AK, et al. Anaphylaxis: a 2023 practice parameter update. Ann Allergy Asthma Immunol. 2024;132:124\u201376.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"2591_CR14","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.bja.2018.04.014","volume":"121","author":"NJN Harper","year":"2018","unstructured":"Harper NJN, Cook TM, Garcez T, Farmer L, Floss K, Marinho S, et al. Anaesthesia, surgery, and life-threatening allergic reactions: epidemiology and clinical features of perioperative anaphylaxis in the 6th National Audit Project (NAP6). Br J Anaesth. 2018;121:159\u201371.","journal-title":"Br J Anaesth"},{"key":"2591_CR15","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1177\/0310057X1704500204","volume":"45","author":"H Kolawole","year":"2017","unstructured":"Kolawole H, Marshall SD, Crilly H, Kerridge R, Roessler P. Australian and New Zealand Anaesthetic Allergy Group\/Australian and New Zealand College of Anaesthetists Perioperative Anaphylaxis Management Guidelines. Anaesth Intensive Care. 2017;45:151\u20138.","journal-title":"Anaesth Intensive Care"},{"key":"2591_CR16","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1007\/s00540-021-03005-8","volume":"35","author":"T Takazawa","year":"2021","unstructured":"Takazawa T, Yamaura K, Hara T, Yorozu T, Mitsuhata H, Morimatsu H, Working Group for the Preparation of Practical Guidelines for the Response to Anaphylaxis, Safety Committee of the Japanese Society of Anesthesiologists. Practical guidelines for the response to perioperative anaphylaxis. J Anesth. 2021;35:778\u201393.","journal-title":"J Anesth."},{"key":"2591_CR17","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/cea.12632","volume":"46","author":"A Trautmann","year":"2016","unstructured":"Trautmann A, Seidl C, Stoevesandt J, Seitz CS. General anaesthesia-induced anaphylaxis: impact of allergy testing on subsequent anaesthesia. Clin Exp Allergy. 2016;46:125\u201332.","journal-title":"Clin Exp Allergy"},{"key":"2591_CR18","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1111\/j.1600-0536.1995.tb02060.x","volume":"33","author":"E K\u00e4mpgen","year":"1995","unstructured":"K\u00e4mpgen E, B\u00fcrger T, Br\u00f6cker EB, Klein CE. Cross-reactive type IV hypersensitivity reactions to benzodiazepines revealed by patch testing. Contact Dermatitis. 1995;33:356\u20137.","journal-title":"Contact Dermatitis"},{"key":"2591_CR19","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1111\/cod.14312","volume":"89","author":"A Buonomo","year":"2023","unstructured":"Buonomo A, Pucci S, De Pasquale TMA. Localized delayed-type hypersensitivity of face and lips from alprazolam and cross-reactivity with other benzodiazepines. Contact Dermatitis. 2023;89:56\u20138.","journal-title":"Contact Dermatitis"},{"key":"2591_CR20","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.anai.2012.01.019","volume":"108","author":"JA Mart\u00ednez-Tadeo","year":"2012","unstructured":"Mart\u00ednez-Tadeo JA, P\u00e9rez-Rodr\u00edguez E, Hern\u00e1ndez-Santana G, Garc\u00eda-Robaina JC, de la Torre-Mor\u00edn F. Anaphylaxis caused by tetrazepam without cross-reactivity with other benzodiazepines. Ann Allergy Asthma Immunol. 2012;108:284\u20135.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"2591_CR21","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/j.jaci.2021.02.012","volume":"147","author":"A Cianferoni","year":"2021","unstructured":"Cianferoni A. Non-IgE-mediated anaphylaxis. J Allergy Clin Immunol. 2021;147:1123\u201331.","journal-title":"J Allergy Clin Immunol"},{"key":"2591_CR22","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1016\/j.bja.2024.01.044","volume":"132","author":"C Tacquard","year":"2024","unstructured":"Tacquard C, Serrier J, Viville S, Chiriac AM, Franchina S, Gouel-Cheron A, et al. Epidemiology of perioperative anaphylaxis in France in 2017\u20132018: the 11th GERAP survey. Br J Anaesth. 2024;132:1230\u20137.","journal-title":"Br J Anaesth."}],"container-title":["BMC Anesthesiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12871-024-02591-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12871-024-02591-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12871-024-02591-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,8]],"date-time":"2024-06-08T06:02:54Z","timestamp":1717826574000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcanesthesiol.biomedcentral.com\/articles\/10.1186\/s12871-024-02591-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,8]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["2591"],"URL":"https:\/\/doi.org\/10.1186\/s12871-024-02591-w","relation":{},"ISSN":["1471-2253"],"issn-type":[{"value":"1471-2253","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,8]]},"assertion":[{"value":"16 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical review and ethical approval were waived for this study due to being a case report and a literature review.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any identifying information\/images in an online open-access publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"204"}}